• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉移植物失败。

Vein graft failure.

机构信息

Division of Vascular and Endovascular Surgery, University of California San Francisco Medical Center, San Francisco, Calif.

Division of Vascular and Endovascular Surgery, University of California San Francisco Medical Center, San Francisco, Calif.

出版信息

J Vasc Surg. 2015 Jan;61(1):203-16. doi: 10.1016/j.jvs.2013.08.019. Epub 2013 Oct 3.

DOI:10.1016/j.jvs.2013.08.019
PMID:24095042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4391818/
Abstract

After the creation of an autogenous lower extremity bypass graft, the vein must undergo a series of dynamic structural changes to stabilize the arterial hemodynamic forces. These changes, which are commonly referred to as remodeling, include an inflammatory response, the development of a neointima, matrix turnover, and cellular proliferation and apoptosis. The sum total of these processes results in dramatic alterations in the physical and biomechanical attributes of the arterialized vein. The most clinically obvious and easily measured of these is lumen remodeling of the graft. However, although somewhat less precise, wall thickness, matrix composition, and endothelial changes can be measured in vivo within the healing vein graft. Recent translational work has demonstrated the clinical relevance of remodeling as it relates to vein graft patency and the systemic factors influencing it. By correlating histologic and molecular changes in the vein, insights into potential therapeutic strategies to prevent bypass failure and areas for future investigation are explored.

摘要

自体下肢旁路移植术后,静脉必须经历一系列动态的结构变化,以稳定动脉血流动力学。这些变化通常被称为重塑,包括炎症反应、新生内膜的形成、基质转换以及细胞增殖和凋亡。这些过程的总和导致动脉化静脉的物理和生物力学特性发生显著改变。这些过程中最具临床意义且最容易测量的是移植物的管腔重塑。然而,尽管不太精确,但在愈合的静脉移植物内,还可以测量壁厚度、基质组成和内皮变化。最近的转化研究表明,重塑与静脉移植物通畅性及其受系统因素影响的相关性具有临床意义。通过对静脉的组织学和分子变化进行相关分析,探讨了预防旁路失败的潜在治疗策略和未来的研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/790b268d85c9/nihms530914f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/f67ee83e11c3/nihms530914f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/213202d50834/nihms530914f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/2192e0c06b2d/nihms530914f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/790b268d85c9/nihms530914f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/f67ee83e11c3/nihms530914f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/213202d50834/nihms530914f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/2192e0c06b2d/nihms530914f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/4391818/790b268d85c9/nihms530914f4.jpg

相似文献

1
Vein graft failure.静脉移植物失败。
J Vasc Surg. 2015 Jan;61(1):203-16. doi: 10.1016/j.jvs.2013.08.019. Epub 2013 Oct 3.
2
Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.清道夫受体A类成员5(SCARA5)和基底层上蛋白(SBSN)是与外周静脉移植通畅相关的共表达网络模块的枢纽基因。
J Vasc Surg. 2016 Jul;64(1):202-209.e6. doi: 10.1016/j.jvs.2014.12.052. Epub 2015 Apr 30.
3
Lower extremity vein graft failure: a translational approach.下肢静脉移植物衰竭:一种转化医学方法。
Vasc Med. 2008 Feb;13(1):63-74. doi: 10.1177/1358863X07083432.
4
A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.p27(Kip1) 基因中的单核苷酸多态性与下肢静脉旁路移植术的初始通畅率相关。
J Vasc Surg. 2013 May;57(5):1179-85.e1-2. doi: 10.1016/j.jvs.2012.11.040. Epub 2013 Jan 9.
5
Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia.血管痉挛和内膜增生的细胞渗透性肽抑制剂。
Vascular. 2013 Feb;21(1):46-53. doi: 10.1258/vasc.2011.201203. Epub 2012 Oct 26.
6
Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass.30 天静脉再塑造可预测下肢旁路术后中期移植物通畅率。
J Vasc Surg. 2013 Jan;57(1):9-18. doi: 10.1016/j.jvs.2012.06.098. Epub 2012 Sep 7.
7
Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.对于严重肢体缺血患者,腹股沟下单节段大隐静脉旁路移植术的效果优于其他自体静脉旁路移植术,尤其是在手术风险较高的患者中。
Ann Vasc Surg. 2012 Apr;26(3):396-403. doi: 10.1016/j.avsg.2011.08.013. Epub 2012 Jan 27.
8
Heterogeneous and dynamic lumen remodeling of the entire infrainguinal vein bypass grafts in patients.患者下肢静脉旁路移植血管整体的异质性和动态管腔重塑。
J Vasc Surg. 2020 May;71(5):1620-1628.e3. doi: 10.1016/j.jvs.2019.05.069. Epub 2019 Oct 11.
9
Clinical factors that influence the cellular responses of saphenous veins used for arterial bypass.影响用于动脉搭桥的隐静脉细胞反应的临床因素。
J Vasc Surg. 2018 Dec;68(6S):165S-176S.e6. doi: 10.1016/j.jvs.2018.03.436. Epub 2018 Jun 15.
10
Introduction of embryonic stem cells into vein grafts reduces intimal hyperplasia in mice.将胚胎干细胞引入静脉移植物可减少小鼠的内膜增生。
J Cardiovasc Surg (Torino). 2014 Apr;55(2):235-46. Epub 2013 Feb 1.

引用本文的文献

1
CD137 Signaling Modulates Vein Graft Atherosclerosis by Driving T-Cell Activation and Regulating Intraplaque Angiogenesis.CD137信号通过驱动T细胞活化和调节斑块内血管生成来调节静脉移植物动脉粥样硬化。
JACC Basic Transl Sci. 2025 Jul 29;10(8):101323. doi: 10.1016/j.jacbts.2025.101323.
2
Mechanobiology research in China.中国的力学生物学研究。
Mechanobiol Med. 2023 Jul 5;1(1):100002. doi: 10.1016/j.mbm.2023.100002. eCollection 2023 Sep.
3
Myocardial Revascularization in Patients with Diabetes and Heart Failure-A Narrative Review.

本文引用的文献

1
Inhibition of neointimal hyperplasia in a rabbit vein graft model following non-viral transfection with human iNOS cDNA.经非病毒转染人 iNOS cDNA 后抑制兔静脉移植物模型中的内膜增生。
Gene Ther. 2013 Oct;20(10):979-86. doi: 10.1038/gt.2013.20. Epub 2013 May 2.
2
Direct proteomic quantification of the secretome of activated immune cells.直接蛋白质组学定量分析激活免疫细胞的分泌组。
Science. 2013 Apr 26;340(6131):475-8. doi: 10.1126/science.1232578.
3
Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal.
糖尿病合并心力衰竭患者的心肌血运重建——一项叙述性综述
Int J Mol Sci. 2025 Apr 5;26(7):3398. doi: 10.3390/ijms26073398.
4
Regeneration of Vascular Endothelium in Different Large Vessels.不同大血管中血管内皮的再生
Int J Mol Sci. 2025 Jan 20;26(2):837. doi: 10.3390/ijms26020837.
5
Fhl1, a new spatially specific protein, regulates vein graft neointimal hyperplasia.Fhl1是一种新的具有空间特异性的蛋白质,可调节静脉移植物新生内膜增生。
Clin Transl Med. 2024 Dec;14(12):e70115. doi: 10.1002/ctm2.70115.
6
Spatial Transcriptomic Profiling of Human Saphenous Vein Exposed to Ex Vivo Arterial Haemodynamics-Implications for Coronary Artery Bypass Graft Patency and Vein Graft Disease.人类隐静脉暴露于体外动脉血流动力学的空间转录组分析 - 对冠状动脉旁路移植通畅性和静脉移植物疾病的影响。
Int J Mol Sci. 2024 Sep 26;25(19):10368. doi: 10.3390/ijms251910368.
7
The Role of Cardio-Renal Inflammation in Deciding the Fate of the Arteriovenous Fistula in Haemodialysis Therapy.心肾炎症在决定血液透析治疗动静脉瘘管命运中的作用。
Cells. 2024 Oct 1;13(19):1637. doi: 10.3390/cells13191637.
8
Early Injury Landscape in Vein Harvest by Single-Cell and Spatial Transcriptomics.单细胞和空间转录组学揭示静脉采集的早期损伤全景。
Circ Res. 2024 Jun 21;135(1):110-134. doi: 10.1161/CIRCRESAHA.123.323939. Epub 2024 May 29.
9
Consensus statement-graft treatment in cardiovascular bypass graft surgery.心血管搭桥移植手术中移植物治疗的共识声明
Front Cardiovasc Med. 2024 Feb 27;11:1285685. doi: 10.3389/fcvm.2024.1285685. eCollection 2024.
10
Therapeutic strategies based on non-ionizing radiation to prevent venous neointimal hyperplasia: the relevance for stenosed arteriovenous fistula, and the role of vascular compliance.基于非电离辐射预防静脉内膜增生的治疗策略:对狭窄动静脉内瘘的相关性及血管顺应性的作用
Front Cardiovasc Med. 2024 Feb 5;11:1356671. doi: 10.3389/fcvm.2024.1356671. eCollection 2024.
Nr4a1 依赖性 Ly6C(low) 单核细胞监测内皮细胞并协调其清除。
Cell. 2013 Apr 11;153(2):362-75. doi: 10.1016/j.cell.2013.03.010.
4
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.D 系列 resolvin 可减轻血管损伤后血管平滑肌细胞的激活和内膜增生。
FASEB J. 2013 Jun;27(6):2220-32. doi: 10.1096/fj.12-225615. Epub 2013 Feb 13.
5
A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.p27(Kip1) 基因中的单核苷酸多态性与下肢静脉旁路移植术的初始通畅率相关。
J Vasc Surg. 2013 May;57(5):1179-85.e1-2. doi: 10.1016/j.jvs.2012.11.040. Epub 2013 Jan 9.
6
Periadventitial human stem cell treatment reduces vein graft intimal thickening in pig vein-into-artery interposition grafts.周细胞源性人干细胞治疗可减少猪静脉动脉间置移植模型静脉移植物内膜增厚。
J Surg Res. 2013 Jul;183(1):33-9. doi: 10.1016/j.jss.2012.11.060. Epub 2012 Dec 20.
7
Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula.超氧阴离子的产生增加导致动静脉瘘功能障碍。
Am J Physiol Renal Physiol. 2012 Dec 15;303(12):F1601-7. doi: 10.1152/ajprenal.00449.2012. Epub 2012 Sep 19.
8
Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice.醛固酮受体拮抗剂抑制小鼠静脉移植物重塑。
J Thorac Cardiovasc Surg. 2013 Jun;145(6):1642-9, 1649.e1. doi: 10.1016/j.jtcvs.2012.08.007. Epub 2012 Sep 13.
9
Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass.30 天静脉再塑造可预测下肢旁路术后中期移植物通畅率。
J Vasc Surg. 2013 Jan;57(1):9-18. doi: 10.1016/j.jvs.2012.06.098. Epub 2012 Sep 7.
10
Protein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodeling.蛋白激酶 N1 是 NFATc1 介导的细胞周期蛋白 D1-CDK6 活性的新底物,调节血管平滑肌细胞的分裂和迁移,导致血管内管壁重塑。
J Biol Chem. 2012 Oct 19;287(43):36291-304. doi: 10.1074/jbc.M112.361220. Epub 2012 Aug 13.